Pedro Lovatt Garcia

Co-Founder & CTO Anzen Industries | Z Fellow

📍 United Kingdom🔄 Updated September 2026💼 2 investments📅 2 years investing🗓 Last invested Jun 2025
VC🌍 United Kingdom
2
Total investments
1
Early stage
0
Mid stage
0
Late stage
2y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor, Observer
Apr 2024
For pharmaceutical and agrochemical companies who need to speed-up process development for organic synthesis. ‍ SOLVE Chemistry™ provides kinetic insights and quantitative yield data to you in a FAIR manner. ‍ Unlike other Al tools, our automated lab collects high-quality quantitative data that powers our proprietary Al models. approaches, we deliver flexible future proof solutions for superior results.
Experience · 4 entries
All (4)
Investments (2)
Founder (1)
2025
Co-Founder & CTO
Sep 2025
Almost every product used in daily life contains molecules derived from nature. From food, to medicines, to materials, 4 billion years of evolution has gifted humanity a wealth of compounds that are integral to the $5T chemical industry. Current approaches to making powerful chemicals from nature are expensive, difficult to scale, and dependent on fragile supply chains. Anzen Industries is building technology to break this constraint. We design and immobilise enzymes in small modular reactors to scale reactions that are otherwise bottlenecked to achieve molecular resilience.
2024
Investor, Observer
Apr 2024
For pharmaceutical and agrochemical companies who need to speed-up process development for organic synthesis. ‍ SOLVE Chemistry™ provides kinetic insights and quantitative yield data to you in a FAIR manner. ‍ Unlike other Al tools, our automated lab collects high-quality quantitative data that powers our proprietary Al models. approaches, we deliver flexible future proof solutions for superior results.
2023
Student Investment Partner
Oct 2023
Creator Fund is a venture capital firm investing in startups on the frontier of whats possible. We back founders building deep technology businesses out of university innovation. We focus on PhD and academic founders and have teams on-the-ground across 28 university campuses. Our portfolio includes founders creating mutation-proof vaccines, electronic skin for robots, and allowing the human mind to control machines. We invest pre-seed and seed and work closely with our companies to scale and raise follow on rounds. CF has been backed by many leading funds in Europe and the US.